See All Slides - tctmd.com

Slides

Presentation TCT 2013

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

Pro(2)

Presenter: Vivek Reddy

October 28, 2013

Presentation TCT 2013

How and When to Use IVUS, OCT, and NIRS for Procedural Guidance

Presenter: Gary Mintz

October 28, 2013

Presentation TCT 2013

2 Case Vignettes in Non-left Main Provisional Stenting: Only 1 Stent Needed

Presenter: Thierry Lefevre

October 28, 2013

Presentation TCT 2013

PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents

Presenter: Laura Mauri

October 28, 2013

Presentation TCT 2013

Editorial Comment: Anatomical and Clinical Considerations for Transcatheter Mitral Valve Repair

Presenter: Francesco Maisano

October 28, 2013

Presentation TCT 2013

A Preview of the Extreme Risk US CoreValve Registry

Presenter: Jeffrey Popma

October 28, 2013

Presentation TCT 2013

Yes! The Multicenter Registry Data Are Compelling

Presenter: Nicolas van Mieghem

October 28, 2013

Presentation TCT 2013

Importance of Incomplete Revascularization after PCI: Anticipating RIVER-PCI

Presenter: Giora Weisz

October 28, 2013

Presentation TCT 2013

Tomorrow's approach? Rationale for and Status of the Collagenase Total Occlusion Trial-2 (CTO-2)

Presenter: Bradley Strauss

October 28, 2013

Advertisement

Slides

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Pro(2)

How and When to Use IVUS, OCT, and NIRS for Procedural Guidance

2 Case Vignettes in Non-left Main Provisional Stenting: Only 1 Stent Needed

PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents

Editorial Comment: Anatomical and Clinical Considerations for Transcatheter Mitral Valve Repair

A Preview of the Extreme Risk US CoreValve Registry

Yes! The Multicenter Registry Data Are Compelling

Importance of Incomplete Revascularization after PCI: Anticipating RIVER-PCI

Tomorrow's approach? Rationale for and Status of the Collagenase Total Occlusion Trial-2 (CTO-2)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content